Aging is a major risk factor for many chronic diseases due to increased vulnerability to external stress and susceptibility to disease. Aging is associated with metabolic liver disease such as nonalcoholic fatty liver. In this study, we investigated changes in lipid metabolism during aging in mice and the mechanisms involved. Lipid accumulation was increased in liver tissues of aged mice, particularly cholesterol. These results suggest that ROS play an important role in altering cholesterol metabolism and consequently contribute to the accumulation of cholesterol in the liver during the aging process.
system (Agarwal, Saleh, & Bedaiwy, 2003; Valko, Morris, & Cronin, 2005) , contributing to the development of many aging-related diseases (Beckman & Ames, 1998; Chandrasekaran, Idelchik, & Melendez, 2017; Sohal, 2002) . In addition, oxidative stress plays an important role in hepatic disease (Cichoz-Lach & Michalak 2014) .
Aging increases fibrotic responses and is also associated with the development of a variety of liver diseases including nonalcoholic fatty liver disease and alcoholic liver disease (Kim, Kisseleva, & Brenner, 2015) . In particular, the prevalence of nonalcoholic fatty liver disease tends to increase with age, and thus, aging and lipid metabolism in the liver may be closely related (Amarapurkar et al., 2007) . In addition, evidence suggests that increased oxidative stress due to various factors leads to increased lipid accumulation in the liver, while decreased oxidative stress has a lipid-lowering effect in hepatocytes (Hassan et al., 2014; Kharroubi et al., 2015; Silva et al., 2015) .
Lipid supply to liver tissue consists of three main pathways: dietary intake, peripheral lipolysis, and de novo lipogenesis (Cogger, Hilmer, & Svistounov, 2011) . Fatty liver occurs when the lipid supply exceeds the hepatic lipid removal. In many previous studies, triglyceride (TG) and cholesterol metabolism disorders and accumulation have been reported to be closely related to aging (Kim et al., 2015; Wang et al., 2013) . For example, in the senescent-associated mouse, the cholesterol content in the liver was increased compared with control mice (Kuhla, Blei, Jaster, & Vollmar, 2011) . In this study, we investigated the mechanisms for the increase in cholesterol accumulation during aging. We found that the increased ROS in aging plays an important role for the accumulation of cholesterol in the liver by increasing cholesterol uptake and cholesterol synthesis via increasing glucose uptake.
| RESULTS

| Serum lipid profiles during aging
To determine changes in serum lipid concentration with aging, total cholesterol, TG, and high-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol levels in serum of different ages of C57BL/6 mice (4, 12, 20, 28 months old) were monitored. 
| Reduced ATP production and increased ROS production in hepatocytes of aged mice
In order to investigate changes in hepatic function with aging, primary hepatocytes were isolated from young (2-month-old) and aged (20-month-old) mice, and the ATP levels were measured as an indicator of mitochondrial function. ATP levels in hepatocytes of 20-month-old mice were significantly reduced compared with that of 2-month-old mice (Figure 1e , p = 0.01). In addition, the ADP/ATP ratio was significantly increased in 20-month-old mice compared with 2-month-old mice (Figure 1f , p = 0.044). The level of ROS, which play a major role in functional deterioration during aging, in hepatocytes of 20-month-old mice, was significantly increased as compared with 2-month-old mice (Figure 1g , p = 0.009). However, the serum levels of serum aspartate transaminase (ALT; Figure 1h ) and alanine transaminase (AST; Figure 1i ), indexes of hepatotoxicity, did not show significant changes with age. These results indicate that liver mitochondrial function declined with age without significant liver damage.
| Increased cholesterol accumulation in the liver of aged mice
In order to investigate the changes in fat accumulation in liver tissues during aging, liver sections from different ages of mice were stained with Oil Red O. As the age increased, the Oil Red O-stained area was increased, indicating that accumulation of fat in the liver increased with aging ( Figure 2a ). When we analyzed TG levels in liver tissue, we found that there were no significant differences among ages (Figure 2b ). However, hepatic cholesterol levels increased with age, with cholesterol levels in 28-month-old mice being significantly increased compared to 8-month-old mice ( Figure 2c , p = 0.0003).
| Increased cholesterol uptake and glucose uptake in hepatocytes of aged mice
As we found that hepatic cholesterol was significantly increased at 28 months, we first checked whether cholesterol uptake in hepatocytes was changed in aged mice. Cholesterol uptake was significantly increased in primary hepatocytes of 20-month-old mice compared with 2-month-old mice. When the hepatocytes were treated with U18666A, a cholesterol uptake stimulator, cholesterol uptake was further increased in 20-month-old mice (Figure 2a ).
Insulin-stimulated glucose uptake in primary hepatocytes from 25-month-old mice was significantly increased over that of 2-monthold mice (Figure 3b ). mRNA expression of glucose transporter 2 (GLUT2; Figure 3c , p = 0.047), which plays an important role in glucose uptake, was observed to increase at 28 months compared with 12 months, and glucokinase (GK; Figure 3d , p = 0.009), a gene related to glycolysis, was also observed to increase at 20 months compared with 2 months. In addition, the mRNA expression levels of genes involved in the synthesis of cholesterol in hepatocytes such as sterol regulatory element-binding protein 2 (SREBP2; Fig- ure 3e, p = 0.006) and 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS; Figure 3g , p = 0.002) were increased in 20-month-old mice, compared to the case for 2-month-old mice, and that of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) was increased in 20-month-old mice, compared to the case for 8-month-old mice (Figure 3f , p = 0.016). These results suggest that increased uptake of glucose in aged mice might contribute to a source for cholesterol synthesis through the glycolysis process. 
| Increased glucose uptake and related factors in H 2 O 2 -treated HepG2 cells and primary hepatocytes
Glucose taken up in liver cells is the source for cholesterol synthesis (Donnelly et al., 2005) . To investigate whether glucose uptake is increased by ROS induction, a glucose uptake assay was performed after treatment with 500 μM H 2 O 2 in HepG2 cells. H 2 O 2 treatment increased both basal and insulin-stimulated glucose uptake (Figure 5d) . As glucose uptake was increased, we checked the translocation of Gut2 protein. We found that GLUT2 expression level in the cytosol was not changed during H 2 O 2 treatment, but GLUT2 expression level in the plasma membrane was significantly increased F I G U R E 3 Cholesterol uptake and glucose uptake cholesterol synthesis-related gene expression were increased in aged mice (n = 3/group). 
| Glucose as a source of cholesterol synthesis in H 2 O 2 -treated HepG2 cells and primary hepatocytes
Although glucose uptake was increased by H 2 O 2 treatment, it was not known whether glucose uptake is used as a source for cholesterol synthesis in HepG2 cells. We first checked the expression of molecules involved in glycolysis. The mRNA and protein levels of GK 
| DISCUSSION
Aging is highly related to the disorders of glucose and lipid metabolism. (Mc Auley & Mooney, 2015; Salmon, 2012) , and hepatic lipid accumulation can contribute to aging-related diseases, including fatty liver, liver cirrhosis, and metabolic syndrome (Sheedfar, Biase, Koonen, & Vinciguerra, 2013) . Hepatic lipid deposition is strictly controlled by a variety of factors including dietary lipid intake, circulating lipid levels, glucose uptake, lipid synthesis, hepatic lipid oxidation, and liver lipid release. (Gong, Tas, Yakar, & Muzumdar, 2017) . Therefore, changes in liver lipid content might be due to the changes in glucose and lipid metabolism. The mechanisms for TG accumulation in the liver in aging have been extensively studied. (Guan et al., 2013; Xiong et al., 2014) . However, there has been little research on the hepatic accumulation of cholesterol following aging.
In this study, a decrease in total serum cholesterol levels was observed in aged mice due to the decrease in HDL cholesterol.
Serum TG levels were also decreased with aging. These results are consistent with the previous report that levels of free fatty acid in serum of aged mice are increased, but TG levels were reduced (Houtkooper et al., 2011) . ATP levels, which indirectly recognize the metabolic function of the liver, were greatly reduced, and ROS levels were significantly increased in hepatocytes of aged mice. These results indicated that hepatic mitochondrial function is damaged by aging. The mitochondria are intracellular organelles that play an important role in glucose and lipid metabolism, and thus, dysfunction of mitochondria in hepatocytes of aged mice might contribute to liver metabolic abnormalities. Our aging animal model showed accumulation of fat in liver evidenced by the increased Oil Red O staining. Our results showed that hepatic cholesterol, but not hepatic TG, increased with age. This phenomenon has also been reported in senescence-accelerated prone mice (SAMP8), an aging animal model (Kuhla et al., 2011) . Therefore, we aimed to investigate the mechanisms of hepatic cholesterol accumulation by aging.
First, we found that cholesterol uptake was increased in primary hepatocytes isolated from aged mice. Another pathway for cholesterol accumulation is de novo synthesis from glucose. The uptaken glucose is oxidized to pyruvate through the glycolysis process and is converted to citrate through the Krebs cycle of mitochondria. The citrate is cleaved to form acetyl-CoA for elongation of fatty acid The expression of mRNA and protein for caveolin-1 and LDLR, which are involved in cholesterol uptake (Ikonen, 2006) , was significantly increased in H 2 O 2 -treated HepG2 cells. An increase in cholesterol uptake was observed in hepatocytes for aged mice. These results suggest that increased ROS can induce the expression of these genes and contribute to the increase in cholesterol uptake.
Glucose uptake and the translocation of GLUT2, a factor associated with glucose uptake, to the cell membrane, were increased in HepG2 cells treated with H 2 O 2 . This result indicates that glucose uptake can also be increased by ROS. De novo synthesis of hepatic lipid is regulated independently by insulin and glucose (Koo, Dutcher, & Towle, 2001 ). In the postprandial state, glucose is taken up into hepatocytes through GLUT2 and phosphorylated to glucose-6-phosphate by hepatic GK (Massa, Gagliardino, & Francini, 2011) , which undergoes glycolysis to produce acetyl-CoA, a source for lipid synthesis (Browning & Horton, 2004) . In this study, the hepatic GK and PKLR, genes related to glycolysis, were significantly increased and acetyl-CoA, levels were also increased in H 2 O 2 -treated HepG2 cells. Therefore, ROS increases glucose uptake and promotes the glycolysis process and thereby increasing fat synthesis in the aged liver.
Glucose-6-phosphate can also be used for glycogen synthesis and storage depending on the systemic metabolic status (von Wilamowitz- Moellendorff et al., 2013) . Therefore, we also examined expression of glycogen-related genes and glycogen content in H 2 O 2 -treated HepG2 cells. The expression of GYS2, which is involved in glycogen synthesis in the liver, was decreased, and the intracellular glycogen level was also decreased by H 2 O 2 treatment. The expression of PYGL, which is involved in glycogen degradation, was not changed. Therefore, it is possible that increased glucose-6-phosphate originating from glucose uptake might be used as a source of lipid synthesis rather than glycogen synthesis. The expression of gluconeogenesis-related factors was also confirmed, but the expression of PEPCK, which acts as a rate-limiting enzyme in the early stage (Chia, Liong, Ton, & Kadir, 2012) , was significantly reduced. Finally, when GLUT2 was knocked down, there was no increase in acetyl-CoA level due to H 2 O 2 treatment, indicating that increased fat synthesis occurred through increased glucose uptake by ROS. 
| Primary hepatocyte isolation
C57BL/6 male mice were anesthetized with ketamine hydrochloride (40 mg/kg) by intraperitoneal injection, and their livers were perfused with a solution of 142 mM NaCl, 6.7 mM KCl, 10 mM HEPES, and 2.5 mM EGTA (pH 7.4). This solution was replaced by 0.5 mg/ml collagenase and 10 mg/ml albumin in 66.7 mM NaCl, 6.7 mM KCl, 10 mM HEPES, 4.8 mM CaCl, pH 7.6. The perfused livers were harvested, rinsed, and disaggregated. After centrifugation, cells were suspended in an appropriate volume of the culture medium (Hepato-ZYME-SFM, Gibco BRL, MA, USA).
| Cell culture
HepG2 (ATCC, Rockville, MD) cells were maintained at subconfluence at 37°C with 5% CO 2 . The cells were grown in DMEM with 10% FBS containing 100 units/ml of penicillin and streptomycin. To establish the aging cell model, HepG2 cells and primary hepatocytes were treated with 500 μM H 2 O 2 for 48 hr.
| Quantification of lipid level of serum, liver tissue, and cells
Blood samples were centrifuged at 3,000 g for 20 min, and serum was collected. Serum levels of total cholesterol, TG, LDL cholesterol, and HDL cholesterol were measured using Beckman Coulter AU680 chemistry analyzer (Beckman Coulter, Inc., CA, USA) . Total lipids were separated from the liver tissue or cells using the Folch method (Folch, Ascoli, Lees, Meath, & Le, 1951) . TG and total cholesterol content was measured using a commercial enzymatic kit (Asan Pharmaceutical Company, Seoul, Korea).
| ATP level and ADT/ATP ratio measurements
The ATP levels and the ADP/ATP ratio of primary hepatocytes were measured using the ADP/ATP Ratio Assay Kit (Abcam, MA, USA).
| Measurement of serum ALT/AST level
Serum ALT/AST was measured using a commercial enzymatic kit (Asan Pharmaceutical Company, Seoul, Korea).
| Measurement of glycogen and acetyl-CoA level of HepG2 cells
Glycogen and acetyl-CoA levels were determined using a commercial enzymatic kit (Biovision).
| ROS detection
For quantification of intracellular ROS levels, primary hepatocytes were loaded with 10 μM 2′, 7′-dichlorodihydrofluorescein diacetate (Molecular Probes, OR, USA) for 30 min at 37°C, 5% CO 2 in phosphate-buffered saline. Cells were collected, washed twice with PBS, and suspended in 500 μl PBS. Fluorescent intensity was measured using FACSCalibur (BD Biosciences, CA, USA) and analyzed by CellQuest Pro 5.2 according to the manufacturer's protocol.
| Oil Red O staining
Liver pieces were embedded in optimal cutting temperature compound. Frozen liver sections were cut at 10 μm thickness, fixed with 10% buffered formalin, dehydrated with 100% propylene glycol, and stained with 0.5% Oil Red O for 30 min at 55°C. Sections were washed repeatedly with 85% propylene glycol followed by distilled water and stained with hematoxylin. Lipid droplets were stained red.
| Glucose and cholesterol uptake assays
For glucose uptake assay, the HepG2 cells or primary hepatocytes were added to the wells of a 96-well plate (1 × 10 4 cells/well) and incubated for 24 hr in growth medium. The growth media were then replaced with medium not containing FBS, and the plates were incubated for another 24 hr. The medium was replaced with KrebsRinger-phosphate-HEPES buffer containing 2% bovine serum albumin. Glucose uptake was determined using a Glucose Uptake Colori- 
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| Western blotting
Cells were harvested, and total protein was extracted or membrane/ cytosol fractionation was carried as described previously (Yamamoto, Yamashita, Yoshioka, Nishiumi, & Ashida, 2016) . Proteins (30-50 μg)
were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred onto membranes, and blocked with 5% 
| Quantitative real-time RT-PCR analysis
Total RNA was extracted from the liver tissue or cells using TRIzol reagent (Invitrogen Corp., CA, USA), following the manufacturer's instructions, and cDNA was synthesized using a PrimeScript 1st strand cDNA synthesis kit (Takara Bio Inc., Kyoto, Japan). Quantitative realtime RT-PCR (qRT-PCR) was performed using the SYBR Premix Ex Taq II, ROX plus (Takara Bio Inc.), and the Prism 7900HT sequence detection system (Applied Biosystems, Foster City, CA, USA). PCR was carried out for 40 cycles (2 min at 50°C, 10 min at 95°C°, and 40 cycles of 10 s at 95°C and 1 min at 60°C). The primer sequences used are shown in Table 1 . The relative copy number was calculated using the threshold crossing point (C t ) as calculated by ΔΔC t .
| siRNA knockdown of GLUT2
HepG2 cells (2 × 10 5 cells) were transfected with GLUT2-siRNA (sc-35495; 10 pmol/L) or control siRNA (sc-44230, 10 pmol/L) (Santa Cruz Biotechnology Inc.) using RNAiMAX (Invitrogen) following the manufacturer's instructions.
| Statistical analyses
All data are expressed as mean ± standard error of at least three independent experiments. Data were analyzed using analysis of variance followed by post hoc analysis using the Tukey range test (GraphPad Prism 7.04 statistical software). p-Values <0.05 were considered statistically significant.
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